Need for Complementary Approach in Primary Parkinson’s Disease: Future Healthcare Perspective
Journal of Natural & Ayurvedic Medicine, 2021 A compilation of varied presentation of symptoms of a Parkinson’s patient is as follows:
openaire +1 more source
Palliative care for Parkinson’s disease: suggestions from a council of patient and carepartners
npj Parkinson's Disease, 2017 In 2015, the Parkinson’s Disease Foundation sponsored the first international meeting on Palliative Care and Parkinson’s disease and the Patient Centered Outcomes Research Institute funded the first comparative effectiveness trial of palliative care for ...
Kirk Hall +4 more
doaj +1 more source
Extended Timed Up and Go assessment as a clinical indicator of cognitive state in Parkinson\u27s disease [PDF]
, 2017 Objective: To evaluate a modified extended Timed Up and Go (extended-TUG) assessment against a panel of validated clinical assessments, as an indicator of Parkinson’s disease (PD) severity and cognitive impairment. Methods: Eighty-seven participants with
Anderton, R +7 more
core +2 more sources
Computer-Aided Diagnosis of Speech Disorder Signal in Parkinson’s Disease
INTERNATIONAL JOURNAL OF COMPUTERS & TECHNOLOGY, 2016 Computer-aided diagnosis (CAD) can be used as a decision support system by physicians in the diagnosis and treatmentof disordered speech especially those who specialize in neurophysiology diseases. Parkinson's disease (PD) is aprogressive disorder of the nervous system that affects movement.
Heba M. Afify, Basma Ahmed
openaire +2 more sources
How Cognition and Motivation “Freeze” the Motor Behavior in Parkinson’s Disease
Frontiers in Neuroscience, 2019 ObjectiveFreezing of gait (FoG) is a debilitating problem in patients with PD. The multifactorial pathogenesis of FoG remains poorly understood. We aimed to find which factors are most strongly associated with the occurrence of FoG.MethodsThree hundred ...
Paola Ortelli +9 more
doaj +1 more source
Drug Repurposing for Parkinson’s Disease: The International Linked Clinical Trials experience
Frontiers in Neuroscience, 2021 The international Linked Clinical Trials (iLCT) program for Parkinson’s to date represents one of the most comprehensive drug repurposing programs focused on one disease.
Simon R. W. Stott +2 more
doaj +1 more source
Cognitive behavioral group therapy versus psychoeducational intervention in Parkinson's disease [PDF]
, 2018 Objective: The aim of the current study was to evaluate whether cognitive behavioral group therapy has a positive impact on psychiatric, and motor and non-motor symptoms in Parkinson’s disease (PD).
Berardelli, Isabella +7 more
core +2 more sources
Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson’s disease [PDF]
, 2017 5-methylcytosine and the oxidation product 5-hydroxymethylcytosine are two prominent epigenetic variants of the cytosine base in nuclear DNA of mammalian brains.
F Shephard +10 more
core +2 more sources
Measuring anxiety in Lewy Body Disease – Which scale to choose?
Clinical Parkinsonism & Related Disorders, 2021 Background: Anxiety is among the most prevalent mood disorders in Lewy Body Disease (LBD) (i.e., Parkinson’s disease (PD), Dementia with Lewy bodies DLB), and those at-risk for developing LBD (e.g. isolated REM Sleep Behaviour Disorder (iRBD)).
Isabel Paniak +2 more
doaj +1 more source
Abnormal connectivity between the default mode and the visual system underlies the manifestation of visual hallucinations in Parkinson’s disease:A task-based fMRI study [PDF]
, 2015 Background: The neural substrates of visual hallucinations remain an enigma, due primarily to the difficulties associated with directly interrogating the brain during hallucinatory episodes.
Halliday, Glenda M. +5 more
core +1 more source